While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

Drugmakers are growing frustrated with the National Health Service after a clawback tax unexpectedly soared, with ...

Ana Botin, executive chair of Spanish bank Santander has denied reports that the company is considering leaving the British ...

The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped ...

Ken Hall looks at three important considerations for investors looking to build a sizeable passive income for a better financial future.

The scrubbing of clinical trial-related pages is notable because of how it could affect the ways researchers both inside and ...

The pipeline will run for about 213 kilometres to a $7.4 billion polyethylene plant where construction started last September ...

PURCHASE, NY. — Rachel Ferdinando has been promoted from president of PepsiCo Foods Canada to chief executive officer of ...

BV100 is a new formulation of rifabutin suitable for intravenous administration, which BioVersys claims offers a new ...

Tata AIG has appointed Shekhar Saurabh as its Head of Marketing. The news has been shared by Saurabh in a LinkedIn update.

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

Children with lupus nephritis who receive belimumab achieve treatment targets faster, and can taper glucocorticoids earlier, than those using standard immunotherapy, according to data published in ...